Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation

Synucleinopathies of the aging population are an heterogeneous group of neurological disorders that includes Parkinson ’s disease (PD) and dementia with Lewy bodies (DLB) and are characterized by the progressiv...
Source: Molecular Neurodegeneration - Category: Neurology Authors: Tags: Research article Source Type: research